Free tool
FAERS Monitor: Toujeo Solostar
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 206538 or its brand name (Toujeo Solostar, Insulin Glargine Recombinant). Reports on generic versions are filed under their own applications.
Reports
49,343
Serious
29,192
59% of reports
Hospitalization
16,376
Death reported
3,008
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood glucose increased6,988
- off label use2,946
- hypoglycaemia2,605
- drug ineffective2,286
- product storage error1,806
- blood glucose decreased1,787
- nausea1,781
- inappropriate schedule of product administration1,694
- diarrhoea1,639
- dyspnoea1,552
- fatigue1,434
- acute kidney injury1,420
- vomiting1,393
- hyperglycaemia1,358
- dizziness1,322
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 99 |
| 2005 | 108 |
| 2006 | 89 |
| 2007 | 111 |
| 2008 | 170 |
| 2009 | 191 |
| 2010 | 299 |
| 2011 | 361 |
| 2012 | 267 |
| 2013 | 406 |
| 2014 | 424 |
| 2015 | 1,591 |
| 2016 | 4,212 |
| 2017 | 3,539 |
| 2018 | 5,057 |
| 2019 | 5,068 |
| 2020 | 3,858 |
| 2021 | 3,611 |
| 2022 | 3,917 |
| 2023 | 3,717 |
| 2024 | 4,203 |
| 2025 | 4,219 |
| 2026 | 3,825 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,004,816 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hypoglycaemiaSignal | 2,605 | 24.1 | 23.2 | 54,774 |
| hyperglycaemiaSignal | 1,358 | 16.5 | 15.6 | 19,006 |
| blood glucose decreasedSignal | 1,787 | 16.4 | 15.7 | 24,986 |
| blood glucose increasedSignal | 6,988 | 16.4 | 16.0 | 98,035 |
| product storage errorSignal | 1,806 | 9.0 | 8.6 | 12,549 |
| inappropriate schedule of product administrationSignal | 1,694 | 4.0 | 3.8 | 3,861 |
| acute kidney injurySignal | 1,420 | 4.0 | 3.8 | 3,163 |
| off label use | 2,946 | 1.4 | 1.4 | 404 |
| vomiting | 1,393 | 1.3 | 1.2 | 78 |
| dyspnoea | 1,552 | 1.2 | 1.1 | 39 |
| dizziness | 1,322 | 1.1 | 1.1 | 20 |
| diarrhoea | 1,639 | 1.1 | 1.0 | 11 |
| nausea | 1,781 | 1.0 | 0.9 | 3 |
| fatigue | 1,434 | 0.8 | 0.7 | 88 |
| drug ineffective | 2,286 | 0.7 | 0.7 | 224 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.